Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Regeneron Pharmaceuticals, Inc. (NQ: REGN)
262.42 USD  +2.46 (+0.95%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 260.06
Bid (Size) 262.42 (700)
Ask (Size) 262.54 (2100)
Prev. Close 259.96
Today's Range 257.08 - 274.50
52wk Range 107.31 - 283.99
Shares Outstanding 95,908,088
Dividend Yield N/A
Top News
More News
iShares Nasdaq Biotechnology Index Fund Experiences Big Outflow
May 22, 2013
Symbols mentioned in this story: IBB, REGN, AMGN, CELG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
May 21, 2013
May 21 (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for... Read More
category companyNews
from Reuters: Company News

More News
Read More
Regeneron Pharmaceuticals Shares Up 53.7% Since SmarTrend's Buy Recommendation (REGN)
May 21, 2013
from Comtex SmarTrend® News Briefs
New Asthma Drug Generates Excitement For Patients -- And Its Maker
May 21, 2013
category NYSE:MRK , NYSE:SNY , NASDAQ:REGN , and 1 more.
from Forbes Real Time
Sanofi (SNY), Regeneron (REGN) Report Publication of Positive Dupilumab Phase 2a Data
May 21, 2013
from StreetInsider.com News Articles
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
May 21, 2013
from PR Newswire
New Asthma Drug Could Be Game Changer
May 21, 2013
category NYSE:SNY , NASDAQ:REGN , Hot Stocks
from InvestorPlace - Latest Headlines
Regeneron settles all pending litigation with Roche's Genentech
May 20, 2013
category companyNews
from Reuters: Company News
Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
May 20, 2013
from StreetInsider.com News Articles
Earnings Look Back: Regeneron Pharmaceuticals Is Up 0.3% Since Reporting Quarterly Results 2 Weeks Ago (REGN)
May 20, 2013
from Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here